An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD
Phase: PHASE1 | Sponsor: Suzanne "Sue" Sisley MD | Compound: Psilocybin
- Status
- recruiting
- Institution
- Sue Sisley
- Start date
- 2025-12-01
- End date
- 2026-03-01
- Registry ID
- NCT07275970
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.